UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 14A INFORMATION
 
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.  )
 
Filed by the Registrant     Filed by a party other than the Registrant
 
Check the appropriate box:

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12
 
ROCKET PHARMACEUTICALS, INC.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):

No fee required
     
Fee paid previously with preliminary materials.
 
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
 


 



Rocket Pharmaceuticals (NASDAQ:RCKT)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Rocket Pharmaceuticals Charts.
Rocket Pharmaceuticals (NASDAQ:RCKT)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Rocket Pharmaceuticals Charts.